Non-Interruptive Alerts for Improving Use of Clinical Decision Rules
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04702308 |
|
Recruitment Status :
Enrolling by invitation
First Posted : January 8, 2021
Last Update Posted : January 11, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Pulmonary Embolism Deep Vein Thrombosis Minor Head Injury Chest Pain Neck Trauma | Other: Clinical Decision Rule Alerts | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 240 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | Cluster randomized controlled trial |
| Masking: | None (Open Label) |
| Primary Purpose: | Diagnostic |
| Official Title: | The Use of Non-Interruptive Alerts for Improving the Use of Clinical Decision Rules in the Emergency Department: A Cluster Randomized Controlled Trial |
| Actual Study Start Date : | February 18, 2021 |
| Actual Primary Completion Date : | November 18, 2021 |
| Estimated Study Completion Date : | July 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Intervention Group
The intervention will contain two components: 1) a non-interruptive best practice advisory (BPA) in the Epic Storyboard and 2) a default suggested calculator tab in the MDCalc Connect app. Six clinical decision rules will be included: Canadian CT Head Rule, Canadian C-spine Rule, HEART Score, PERC Rule, Wells' PE Criteria and Wells' DVT Criteria. Predefined criteria based on chief complaint, patient age and vital signs will be used to determine when a decision rule may be relevant in a patient encounter. When a patient meets all of the predefined criteria, the intervention will be triggered.
|
Other: Clinical Decision Rule Alerts
The |
|
No Intervention: Control Group
The control group will be usual care. Specifically, providers in the control group will not receive the clinical decision rule alert or the default suggested calculator tab in the MDCalc Connect app. The control group providers will have access to the MDCalc Connect app in its standard form and functionality.
|
- Total clinical decision rule usage [ Time Frame: During the intervention ]Composite measure of total number of clinical decision rules used through the MDCalc Connect app.
- Individual clinical decision rule usage [ Time Frame: During the intervention ]Number of uses of individual clinical decision rules measured through the MDCalc Connect app.
- Computed tomography pulmonary angiography studies [ Time Frame: During the intervention ]The total number of computed tomography pulmonary angiography studies ordered
- Computed tomography head studies [ Time Frame: During the intervention ]The total number of computed tomography head without contrast studies ordered
- Computed tomography c-spine studies [ Time Frame: During the intervention ]The total number of computed tomography c-spine without contrast studies ordered
- Lower extremity ultrasound [ Time Frame: During the intervention ]The total number of lower extremity ultrasound studies ordered
- d-dimer tests [ Time Frame: During the intervention ]Total number of d-dimer blood tests ordered
- Delta troponin tests [ Time Frame: During the intervention ]Total number of times two or more troponin tests were ordered
- Emergency department bounceback rate. [ Time Frame: Up to 30 days after the intervention ]30-day emergency department return visit (or "bounceback") rate
- Admission rate [ Time Frame: During the intervention ]Hospital admission rate
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 16 Years and older (Child, Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Patient Inclusion Criteria:
- 16 years of age or older
- Qualifying chief complaint*
Patient Exclusion Criteria:
-
None
- A full list of the qualifying chief complaints is provided in Appendix A of the full research protocol.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04702308
| United States, Utah | |
| University of Utah | |
| Salt Lake City, Utah, United States, 84112 | |
Documents provided by Keaton Morgan, University of Utah:
| Responsible Party: | Keaton Morgan, Postdoctoral Fellow, University of Utah |
| ClinicalTrials.gov Identifier: | NCT04702308 |
| Other Study ID Numbers: |
00137874 |
| First Posted: | January 8, 2021 Key Record Dates |
| Last Update Posted: | January 11, 2022 |
| Last Verified: | January 2022 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
clinical decision support clinical decision rules |
|
Pulmonary Embolism Craniocerebral Trauma Thrombosis Embolism Venous Thrombosis Chest Pain Embolism and Thrombosis Vascular Diseases |
Cardiovascular Diseases Lung Diseases Respiratory Tract Diseases Pain Neurologic Manifestations Trauma, Nervous System Nervous System Diseases Wounds and Injuries |

